T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update
Tài liệu tham khảo
Chan, 2019, Haematolymphoid tumours of the digestive system, Vol 1
Jaffe, 2017, Intestinal T-cell lymphoma
Swinson, 1983, Coeliac disease and malignancy, Lancet, 1, 111, 10.1016/S0140-6736(83)91754-3
Green, 2007, Celiac disease, N Engl J Med, 357, 1731, 10.1056/NEJMra071600
Malamut, 2013, Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study, Dig Liver Dis, 45, 377, 10.1016/j.dld.2012.12.001
Chander, 2018, Pathogenesis of enteropathy-associated T-cell lymphoma, Curr Hematol Malig Rep, 13, 308, 10.1007/s11899-018-0459-5
Delabie, 2011, Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project, Blood, 118, 148, 10.1182/blood-2011-02-335216
Daum, 2003, Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma, J Clin Oncol, 21, 2740, 10.1200/JCO.2003.06.026
Gale, 2000, Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center, J Clin Oncol, 18, 795, 10.1200/JCO.2000.18.4.795
Sieniawski, 2010, Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation, Blood, 115, 3664, 10.1182/blood-2009-07-231324
Biagi, 2010, Mortality in celiac disease, Nat Rev Gastroenterol Hepatol, 7, 158, 10.1038/nrgastro.2010.2
Al-Toma, 2006, Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma, Clin Gastroenterol Hepatol, 4, 315, 10.1016/j.cgh.2005.12.011
Di Sabatino, 2012, How I treat enteropathy-associated T-cell lymphoma, Blood, 119, 2458, 10.1182/blood-2011-10-385559
Al-Toma, 2007, Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience, Gut, 56, 1373, 10.1136/gut.2006.114512
Malamut, 2009, Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II, Gastroenterology, 136, 81, 10.1053/j.gastro.2008.09.069
Rubio-Tapia, 2010, Classification and management of refractory coeliac disease, Gut, 59, 547, 10.1136/gut.2009.195131
van Gils, 2015, Mechanisms and management of refractory coeliac disease, Nat Rev Gastroenterol Hepatol, 12, 572, 10.1038/nrgastro.2015.155
Smedby, 2005, Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma, Gut, 54, 54, 10.1136/gut.2003.032094
Amiot, 2012, High frequency of fatal haemophagocytic lymphohistiocytosis syndrome in enteropathy-associated T cell lymphoma, Dig Liver Dis, 44, 343, 10.1016/j.dld.2011.10.008
Isaacson, 2005, Gastrointestinal lymphoma: where morphology meets molecular biology, J Pathol, 205, 255, 10.1002/path.1703
Isaacson, 2017, Enteropathy-associated T-cell lymphoma and other primary intestinal T-cell lymphomas
Schwock, 2015, Enteropathy-associated intestinal T-cell lymphoma in cavitating mesenteric lymph node syndrome: fine-needle aspiration contributes to the diagnosis, Diagn Cytopathol, 43, 125, 10.1002/dc.23144
Matuchansky, 1984, Cavitation of mesenteric lymph nodes, splenic atrophy, and a flat small intestinal mucosa. Report of six cases, Gastroenterology, 87, 606, 10.1016/0016-5085(84)90533-X
Holmes, 1986, Mesenteric lymph node cavitation in coeliac disease, Gut, 27, 728, 10.1136/gut.27.6.728
Howat, 1995, Cavitation of mesenteric lymph nodes: a rare complication of coeliac disease, associated with a poor outcome, Histopathology, 27, 349, 10.1111/j.1365-2559.1995.tb01525.x
Chott, 1998, Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology, Am J Pathol, 153, 1483, 10.1016/S0002-9440(10)65736-7
Murray, 1995, Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma, Am J Pathol, 146, 509
Nicolae, 2016, Mutations in the JAK/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas, Leukemia, 30, 2245, 10.1038/leu.2016.178
Attygalle, 2014, Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward – report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology, Histopathology, 64, 171, 10.1111/his.12251
Hussein, 2018, Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease, J Clin Pathol, 71, 825, 10.1136/jclinpath-2018-205023
Daum, 2009, High rates of complications and substantial mortality in both types of refractory sprue, Eur J Gastroenterol Hepatol, 21, 66, 10.1097/MEG.0b013e328307c20c
Ilus, 2014, Refractory coeliac disease in a country with a high prevalence of clinically-diagnosed coeliac disease, Aliment Pharmacol Ther, 39, 418, 10.1111/apt.12606
Roshan, 2011, The incidence and clinical spectrum of refractory celiac disease in a North American referral center, Am J Gastroenterol, 106, 923, 10.1038/ajg.2011.104
Rubio-Tapia, 2009, Clinical staging and survival in refractory celiac disease: a single center experience, Gastroenterology, 136, 99, 10.1053/j.gastro.2008.10.013
Cellier, 1998, Abnormal intestinal intraepithelial lymphocytes in refractory sprue, Gastroenterology, 114, 471, 10.1016/S0016-5085(98)70530-X
Farstad, 2002, Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression, Gut, 51, 372, 10.1136/gut.51.3.372
Verbeek, 2008, Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in refractory celiac disease, Clin Immunol, 126, 48, 10.1016/j.clim.2007.09.002
Verbeek, 2009, Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization, Cytometry B Clin Cytom, 76, 367, 10.1002/cyto.b.20481
van Wanrooij, 2014, Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease, J Clin Immunol, 34, 828, 10.1007/s10875-014-0075-7
van Wanrooij, 2010, Accurate classification of RCD requires flow cytometry, Gut, 59, 1732, 10.1136/gut.2010.223438
Verkarre, 2003, Refractory coeliac sprue is a diffuse gastrointestinal disease, Gut, 52, 205, 10.1136/gut.52.2.205
Cellier, 2000, Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group, Lancet, 356, 203, 10.1016/S0140-6736(00)02481-8
Carbonnel, 1998, Are complicated forms of celiac disease cryptic T-cell lymphomas?, Blood, 92, 3879, 10.1182/blood.V92.10.3879
Bagdi, 1999, Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population, Blood, 94, 260, 10.1182/blood.V94.1.260.413k40_260_264
Ashton-Key, 1997, Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma, Am J Pathol, 151, 493
Zettl, 2002, Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma, Am J Pathol, 161, 1635, 10.1016/S0002-9440(10)64441-0
Zettl, 2007, Enteropathy-type T-cell lymphoma, Am J Clin Pathol, 127, 701, 10.1309/NW2BK1DXB0EQG55H
Deleeuw, 2007, Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes, Gastroenterology, 132, 1902, 10.1053/j.gastro.2007.03.036
Moffitt, 2017, Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2, J Exp Med, 214, 1371, 10.1084/jem.20160894
Egan, 1995, Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era, J Clin Gastroenterol, 21, 123, 10.1097/00004836-199509000-00012
de Baaij, 2015, A new and validated clinical prognostic model (EPI) for enteropathy-associated T-cell lymphoma, Clin Cancer Res, 21, 3013, 10.1158/1078-0432.CCR-14-2195
Swerdlow, 2014, International Lymphoma Study Group. Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies, Am J Surg Pathol, 38, 60, 10.1097/PAS.0000000000000295
Chan, 2011, Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression, Am J Surg Pathol, 35, 1557, 10.1097/PAS.0b013e318222dfcd
Ko, 2010, Enteropathy-associated T-cell lymphoma—a clinicopathologic and array comparative genomic hybridization study, Hum Pathol, 41, 1231, 10.1016/j.humpath.2009.11.020
Tse, 2012, Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia lymphoma study group, Am J Hematol, 87, 663, 10.1002/ajh.23213
Tan, 2013, Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype, Leukemia, 27, 1688, 10.1038/leu.2013.41
Tomita, 2015, Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan, Mod Pathol, 28, 1286, 10.1038/modpathol.2015.85
Kikuma, 2014, Detailed clinicopathological characteristics and possible lymphomagenesis of type II intestinal enteropathy-associated T-cell lymphoma in Japan, Hum Pathol, 45, 1276, 10.1016/j.humpath.2013.10.038
Mutzbauer, 2018, SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma, Mod Pathol, 31, 505, 10.1038/modpathol.2017.145
Tan, 2011, Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma, Leukemia, 25, 555, 10.1038/leu.2010.295
Roberti, 2016, Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations, Nat Commun, 7, 12602, 10.1038/ncomms12602
Wang, 1995, Consistent presence of isochromosome 7q in hepatosplenic T gamma/delta lymphoma: a new cytogenetic-clinicopathologic entity, Genes Chromosomes Cancer, 12, 161, 10.1002/gcc.2870120302
McKinney, 2017, The genetic basis of hepatosplenic T-cell lymphoma, Cancer Discov, 7, 369, 10.1158/2159-8290.CD-16-0330
Nairismägi, 2016, JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma, Leukemia, 30, 1311, 10.1038/leu.2016.13
Carbonnel, 1994, Extensive small intestinal T-cell lymphoma of low-grade malignancy associated with a new chromosomal translocation, Cancer, 73, 1286, 10.1002/1097-0142(19940215)73:4<1286::AID-CNCR2820730425>3.0.CO;2-9
Egawa, 1995, Relapsing oral and colonic ulcers with monoclonal T-cell infiltration. A low grade mucosal T-lymphoproliferative disease of the digestive tract, Cancer, 75, 1728, 10.1002/1097-0142(19950401)75:7<1728::AID-CNCR2820750727>3.0.CO;2-9
Tsutsumi, 1996, T-cell lymphomas diffusely involving the intestine: report of two rare cases, Jpn J Clin Oncol, 26, 264, 10.1093/oxfordjournals.jjco.a023226
Hirakawa, 1996, Primary gastrointestinal T-cell lymphoma resembling multiple lymphomatous polyposis, Gastroenterology, 111, 778, 10.1053/gast.1996.v111.pm8780585
Carbonnel, 1999, The clinicopathological features of extensive small intestinal CD4 T cell infiltration, Gut, 45, 662, 10.1136/gut.45.5.662
Ranheim, 2000, Spontaneously relapsing clonal, mucosal cytotoxic T-cell lymphoproliferative disorder: case report and review of the literature, Am J Surg Pathol, 24, 296, 10.1097/00000478-200002000-00017
Isomoto, 2004, Multiple lymphomatous polyposis of the colon originating from T-cells: a case report, Dig Liver Dis, 36, 218, 10.1016/j.dld.2003.09.019
Zivny, 2004, CD4+ T-cell lymphoproliferative disorder of the gut clinically mimicking celiac sprue, Dig Dis Sci, 49, 551, 10.1023/B:DDAS.0000026297.25591.62
Svrcek, 2007, Small intestinal CD4+ T-cell lymphoma: a rare distinctive clinicopathological entity associated with prolonged survival, Virchows Arch, 451, 1091, 10.1007/s00428-007-0475-7
Margolskee, 2013, Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features, PLoS One, 8, 10.1371/journal.pone.0068343
Perry, 2013, Indolent T-cell lymphoproliferative disease of the gastrointestinal tract, Blood, 122, 3599, 10.1182/blood-2013-07-512830
Leventaki, 2014, Indolent peripheral T-cell lymphoma involving the gastrointestinal tract, Hum Pathol, 45, 421, 10.1016/j.humpath.2013.08.003
Malamut, 2014, Small intestinal CD4+ T-cell lymphoma is a heterogenous entity with common pathology features, Clin Gastroenterol Hepatol, 12, 599, 10.1016/j.cgh.2013.11.028
Sena Teixeira Mendes, 2014, CD4-positive small T-cell lymphoma of the intestine presenting with severe bile-acid malabsorption: a supportive symptom control approach, Br J Haematol, 167, 265, 10.1111/bjh.12953
Sharma, 2018, Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract, Blood, 131, 2262, 10.1182/blood-2018-01-830968
Perry, 2019, Disease progression in a patient with indolent T-cell lymphoproliferative disease of the gastrointestinal tract, Int J Surg Pathol, 27, 102, 10.1177/1066896918785985
Sun, 2011, Primary intestinal T-cell and NK-cell lymphomas: a clinicopathological and molecular study from China focused on type II enteropathy-associated T-cell lymphoma and primary intestinal NK-cell lymphoma, Mod Pathol, 24, 983, 10.1038/modpathol.2011.45
Kawamoto, 2009, Clinicopathological characteristics of primary gastric T-cell lymphoma, Histopathology, 55, 641, 10.1111/j.1365-2559.2009.03430.x
Park, 2014, Peripheral T cell lymphoma in Asia, Int J Hematol, 99, 227, 10.1007/s12185-014-1520-3
Kim, 2011, Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL), BMC Cancer, 11, 321, 10.1186/1471-2407-11-321
Holanda, 2008, Primary gastric T cell lymphoma mimicking marginal zone B cell lymphoma of mucosa-associated lymphoid tissue, J Hematop, 1, 29
Vega, 2006, Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease, Am J Surg Pathol, 30, 539, 10.1097/00000478-200604000-00017
Mansoor, 2011, NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series, Blood, 117, 1447, 10.1182/blood-2010-08-302737
Xia, 2019, NK-cell enteropathy and similar indolent lymphoproliferative disorders: a case series with literature review, Am J Clin Pathol, 151, 75
Xiao, 2019, Recurrent somatic JAK3 mutations in NK-cell enteropathy, Blood, 134, 986, 10.1182/blood.2019001443
Takeuchi, 2010, Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation, Blood, 116, 5631, 10.1182/blood-2010-06-290650
Takata, 2015, Clinicopathologic analysis of 6 lymphomatoid gastropathy cases: expanding the disease spectrum to CD4-CD8+ cases, Am J Surg Pathol, 39, 1259, 10.1097/PAS.0000000000000443
Yamamoto, 2011, A case of benign natural killer cell proliferative disorder of the stomach (gastric manifestation of natural killer cell lymphomatoid gastroenteropathy) mimicking extranodal natural killer/T-cell lymphoma, Leuk Lymphoma, 52, 1803, 10.3109/10428194.2011.573030
Tanaka, 2011, A case of lymphomatoid gastropathy: an indolent CD56-positive atypical gastric lymphoid proliferation, mimicking aggressive NK/T cell lymphomas, Pathol Res Pract, 207, 786, 10.1016/j.prp.2011.09.012
Terai, 2012, Lymphomatoid gastropathy mimicking extranodal NK/T cell lymphoma, nasal type: a case report, World J Gastroenterol, 18, 2140, 10.3748/wjg.v18.i17.2140
Ishibashi, 2013, A case of lymphomatoid gastropathy: a self-limited pseudomalignant natural killer (NK)-cell proliferative disease mimicking NK/T-cell lymphomas, Clin J Gastroenterol, 6, 287, 10.1007/s12328-013-0397-7
Koh, 2014, Benign indolent CD56-positive NK-cell lymphoproliferative lesion involving gastrointestinal tract in an adolescent, Korean J Pathol, 48, 73, 10.4132/KoreanJPathol.2014.48.1.73
Hwang, 2016, Indolent NK cell proliferative lesion mimicking NK/T cell lymphoma in the gallbladder, Hum Pathol Case Rep, 5, 39, 10.1016/j.ehpc.2016.01.004
Wang, 2019, NK-cell enteropathy, a potential diagnostic pitfall of intestinal lymphoproliferative disease, Pathology, 51, 338, 10.1016/j.pathol.2018.09.064